|
PPP1R12A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.033700E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.464300E-03 |
| Normal-vs-Stage2 |
2.649000E-01 |
| Normal-vs-Stage3 |
5.712400E-01 |
| Normal-vs-Stage4 |
4.710600E-01 |
| Stage1-vs-Stage2 |
5.627200E-01 |
| Stage1-vs-Stage3 |
1.681420E-01 |
| Stage1-vs-Stage4 |
5.286400E-01 |
| Stage2-vs-Stage3 |
5.884600E-01 |
| Stage2-vs-Stage4 |
8.635400E-01 |
| Stage3-vs-Stage4 |
8.035800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.232200E-02 |
| Normal-vs-AfricanAmerican |
1.940040E-01 |
| Normal-vs-Asian |
4.399000E-01 |
| Caucasian-vs-AfricanAmerican |
6.129000E-01 |
| Caucasian-vs-Asian |
8.625200E-01 |
| AfricanAmerican-vs-Asian |
9.968800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.014460E-02 |
| Normal-vs-Female |
8.120800E-01 |
| Male-vs-Female |
8.736000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.983600E-02 |
| Normal-vs-Extreme_Weight |
2.061700E-03 |
| Normal-vs-Obese |
2.804800E-01 |
| Normal-vs-Extreme_Obese |
1.183640E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.261000E-01 |
| Normal_Weight-vs-Obese |
3.790400E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.138200E-01 |
| Extreme_Weight-vs-Obese |
5.553700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.931600E-01 |
| Obese-vs-Extreme_Obese |
1.800350E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.562410E-01 |
| Normal-vs-Age(41-60Yrs) |
4.630600E-01 |
| Normal-vs-Age(61-80Yrs) |
2.121500E-03 |
| Normal-vs-Age(81-100Yrs) |
6.317600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.064100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.335110E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.424400E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.059200E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.809900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.156200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.714200E-02 |
| Normal-VS-Type2 PRCC |
3.922100E-03 |
| Normal-VS-KIRP CIMP |
1.617160E-01 |
| Normal-VS-Unclassified PRCC |
8.553600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.516100E-02 |
| Type1 PRCC-VS-KIRP CIMP |
6.418700E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
9.024000E-02 |
| Type2 PRCC-VS-KIRP CIMP |
6.160800E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
1.972030E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.142600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.216500E-03 |
| Normal-vs-N1 |
3.352000E-01 |
| Normal-vs-N2 |
8.718600E-01 |
| N0-vs-N1 |
3.503100E-03 |
| N0-vs-N2 |
2.466200E-01 |
| N1-vs-N2 |
7.432200E-01 |
|
|
